£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

US Anti-Migraine Drug Market Outlook 2016-2021 Study

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days · 88 data points

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 11 August 2026 01 September 2026 23 September 2026 15 October 2026 06 November 2026
View at Amazon ↗

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 88 days • 1 price levels

Days at Price
88 days 0 22 44 66 88 £595 Days at Price

Price Analysis

Most common price: £595 (88 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 88 days

Description

This econometric study provides a detailed analysis of the latent demand for anti-migraine drugs in the United States from 2016 to 2021. By utilizing econometric models, the research estimates potential industry earnings (P.I.E.) across approximately 12,700 cities. Readers can access specific data regarding the latent demand in millions of U.S. dollars for various locations. The study includes comparative benchmarks by reporting the percent share each city holds within its state and across the entire United States. This statistical approach is designed to assist professionals in developing effective distribution and sales force strategies through precise geographic market insights.

Key Features

Provides latent demand estimates in millions of U.S. dollars for anti-migraine drugs across the United States.

Includes potential industry earnings (P.I.E.) data for approximately 12,700 cities.

Offers comparative benchmarks by reporting the percent share of each city relative to its state and the nation.

Uses econometric models to deliver statistical insights for market analysis.

Supports the development of distribution and sales force strategies through detailed geographic data.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
31 August 2015
Listed Since
16 September 2015

Similar Products You Might Like

The 2016-2021 Outlook for Anti-Migraine Drugs in India
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in India

£595.00 03 Nov 2026
Anti-Migraine Drug Outlook in Greater China 2016-2021
99% match

Anti-Migraine Drug Outlook in Greater China 2016-2021

£595.00 25 Aug 2026
US Anti-Migraine Drug Market Outlook 2023-2028 Study
99% match

US Anti-Migraine Drug Market Outlook 2023-2028 Study

£520.00 07 Nov 2026
Anti-Migraine Drugs in India Outlook 2023-2028 Study
99% match

Anti-Migraine Drugs in India Outlook 2023-2028 Study

£515.00 09 Nov 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
99% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 24 Aug 2026
Anti-Migraine Drug Outlook Latin America 2016-2021 Study
99% match

Anti-Migraine Drug Outlook Latin America 2016-2021 Study

£425.00 07 Nov 2026
Anti-Migraine Drug Outlook: Africa & Middle East Study
99% match

Anti-Migraine Drug Outlook: Africa & Middle East Study

£425.00 05 Nov 2026
The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City
99% match

The 2016 Report on Anti-Migraine Drugs: World Market Segmentation by City

£995.00 28 Oct 2026
Anti-Migraine Drug Outlook in Asia 2016-2021 Study
99% match

Anti-Migraine Drug Outlook in Asia 2016-2021 Study

£425.00 06 Nov 2026
Anti-Migraine Drug Outlook North America & Caribbean Study
99% match

Anti-Migraine Drug Outlook North America & Caribbean Study

£425.00 05 Nov 2026
Anti-Migraine Drugs in Europe Outlook 2016-2021 Report
99% match

Anti-Migraine Drugs in Europe Outlook 2016-2021 Report

£425.00 09 Nov 2026
Anti-Migraine Drug Outlook in Middle East (2011-2016)
99% match

Anti-Migraine Drug Outlook in Middle East (2011-2016)

£325.00 24 Aug 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
98% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

£325.00 05 Nov 2026
Anti-Migraine Drug Outlook in Oceana 2016-2021 Study
98% match

Anti-Migraine Drug Outlook in Oceana 2016-2021 Study

£425.00 26 Sep 2026
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
98% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 07 Nov 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in China
98% match

The 2023-2028 Outlook for Anti-Migraine Drugs in China

£495.00 04 Nov 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in Japan
98% match

The 2023-2028 Outlook for Anti-Migraine Drugs in Japan

£495.00 29 Oct 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Africa
98% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Africa

£325.00 31 Oct 2026
2025-2030 World Outlook for Anti-Migraine Drugs Study
98% match

2025-2030 World Outlook for Anti-Migraine Drugs Study

Price unavailable
US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study
98% match

US Anti-Migraine Drug Outlook 2023-2028 - Zip Code Study

£490.00 04 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
The 2026-2031 World Outlook for Pain Management Devices
97% match

The 2026-2031 World Outlook for Pain Management Devices

£885.00 06 Nov 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026